Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Triumvira Immunologics Inc.
Headquarters: Austin, TX, United States of America
Website: http://www.triumvira.com
Year Founded: 2015
Status: Private
BioCentury | Nov 26, 2024
Management Tracks
Susanna High named CEO of Paragon
Plus: Lee Patterson becomes CEO of Metrion, and updates from Rondo, AffyImmune and Aspargo
BioCentury | Jul 21, 2023
Management Tracks
Ann Lee-Karlon named CEO of EpiBiologics
Plus: Haas becomes CEO at LimmaTech, and updates from Sagimet, Agenus, Triumvira and Passage Bio
BioCentury | Jan 19, 2023
Management Tracks
Janssen’s Linda Wu to head development at Jiangsu Yahong
Plus: new CEO at Atriva, and updates from Hinge Bio, Capsida, Sensorium, CXL and Patient Square
BioCentury | Oct 25, 2022
Management Tracks
Williamson made president and CBO of Triumvira
Plus new heads of strategy, CMC at Actinium, and updates from Telegraph Hill and Sebela
BioCentury | Jun 24, 2022
Data Byte
CAR T cells headline HER2 cell therapy pipeline
CAR T cells are the most popular strategy to hit the solid tumor-selective target, but companies are using at least five other methods
BioCentury | Mar 26, 2022
Emerging Company Profile
Affini-T: engineering T cells to target oncogenic drivers in solid tumors
With $175M in the bank, Fred Hutch spinout is adding synthetic biology switches to T cells to increase their tumor infiltration and persistence
BioCentury | Mar 17, 2022
Finance
March 17 Quick Takes: MPP brings royalty-free Paxlovid to 95 countries
Plus China stocks rise again, Deepcell raises and updates from Qbic, AbbVie and more
BioCentury | Jan 20, 2022
Management Tracks
GSK’s Thirsk joins Bavarian Nordic as COO
Plus Baroldi, Bastings join Ionis, and updates from Exscientia,
BioCentury | Oct 28, 2021
Management Tracks
Murphy leaving Kinnate as CSO
Adib replaces Chlosta at Triumvira, plus Integra, Inscopix, CinCor, PepGen and Temedica
BioCentury | Apr 28, 2021
Management Tracks
Jefferson named FDA associate commissioner for external affairs; plus Surface, StrideBio, Himalaya and more
HHS named Erica Jefferson FDA associate commissioner for external affairs. Jefferson served as a spokesperson and acting assistant commissioner for media affairs at the agency during the Obama
Items per page:
1 - 10 of 18